149 related articles for article (PubMed ID: 37432513)
21. [Regulation of TRIP13 on Proliferation and Apoptosis of B-Cell Lymphoma Cells and Its Mechanism].
Yan SR; Zhang Q; Liu XC; Yuan JJ; Zhang F; Zhou KS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1485-1492. PubMed ID: 34627428
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic silencing of microRNA-204 by Helicobacter pylori augments the NF-κB signaling pathway in gastric cancer development and progression.
Chen P; Guo H; Wu X; Li J; Duan X; Ba Q; Wang H
Carcinogenesis; 2020 Jun; 41(4):430-441. PubMed ID: 31873718
[TBL] [Abstract][Full Text] [Related]
23. TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myeloma.
Tao Y; Yang G; Yang H; Song D; Hu L; Xie B; Wang H; Gao L; Gao M; Xu H; Xu Z; Wu X; Zhang Y; Zhu W; Zhan F; Shi J
Oncotarget; 2017 Apr; 8(16):26718-26731. PubMed ID: 28157697
[TBL] [Abstract][Full Text] [Related]
24. Fas-associated factor 1 inhibits tumor growth by suppressing Helicobacter pylori-induced activation of NF-κB signaling in human gastric carcinoma.
Liu AQ; Xie Z; Chen XN; Feng J; Chen JW; Qin FJ; Ge LY
Oncotarget; 2017 Jan; 8(5):7999-8009. PubMed ID: 28030825
[TBL] [Abstract][Full Text] [Related]
25. TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway.
Xiao Z; Li M; Zhang X; Rong X; Xu H
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36896765
[TBL] [Abstract][Full Text] [Related]
26. Thyroid Receptor-Interacting Protein 13 is Correlated with Progression and Poor Prognosis in Bladder Cancer.
Niu L; Gao Z; Cui Y; Yang X; Li H
Med Sci Monit; 2019 Sep; 25():6660-6668. PubMed ID: 31486418
[TBL] [Abstract][Full Text] [Related]
27. TRIP13 exerts a cancer-promoting role in cervical cancer by enhancing Wnt/β-catenin signaling via ACTN4.
Liu X; Shen X; Zhang J
Environ Toxicol; 2021 Sep; 36(9):1829-1840. PubMed ID: 34061428
[TBL] [Abstract][Full Text] [Related]
28. TRIP13 upregulation is correlated with poor prognosis and tumor progression in esophageal squamous cell carcinoma.
Di S; Li M; Ma Z; Guo K; Li X; Yan X
Pathol Res Pract; 2019 Jun; 215(6):152415. PubMed ID: 31064720
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-κB signaling.
Xia JT; Chen LZ; Jian WH; Wang KB; Yang YZ; He WL; He YL; Chen D; Li W
J Transl Med; 2014 Feb; 12():33. PubMed ID: 24495516
[TBL] [Abstract][Full Text] [Related]
30. RPS15A promotes gastric cancer progression via activation of the Akt/IKK-β/NF-κB signalling pathway.
Liu C; He X; Liu X; Yu J; Zhang M; Yu F; Wang Y
J Cell Mol Med; 2019 Mar; 23(3):2207-2218. PubMed ID: 30661291
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the TRIP13 level in breast cancer and insights into potential molecular pathways.
Lan J; Huang J; Tao X; Gao Y; Zhang L; Huang W; Luo J; Liu C; Deng Y; Liu L; Liu X
J Cell Mol Med; 2022 May; 26(9):2673-2685. PubMed ID: 35322916
[TBL] [Abstract][Full Text] [Related]
32. let-7b/g silencing activates AKT signaling to promote gastric carcinogenesis.
Kang W; Tong JH; Lung RW; Dong Y; Yang W; Pan Y; Lau KM; Yu J; Cheng AS; To KF
J Transl Med; 2014 Oct; 12():281. PubMed ID: 25288334
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA KRT19P3 suppresses proliferation and metastasis through COPS7A-mediated NF-κB pathway in gastric cancer.
Zheng J; Zhang H; Ma R; Liu H; Gao P
Oncogene; 2019 Nov; 38(45):7073-7088. PubMed ID: 31409899
[TBL] [Abstract][Full Text] [Related]
34. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
35. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ
Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164
[TBL] [Abstract][Full Text] [Related]
36. TRIP13 promotes tumor growth and is associated with poor prognosis in colorectal cancer.
Sheng N; Yan L; Wu K; You W; Gong J; Hu L; Tan G; Chen H; Wang Z
Cell Death Dis; 2018 Mar; 9(3):402. PubMed ID: 29540729
[TBL] [Abstract][Full Text] [Related]
37. LINC01410-miR-532-NCF2-NF-kB feedback loop promotes gastric cancer angiogenesis and metastasis.
Zhang JX; Chen ZH; Chen DL; Tian XP; Wang CY; Zhou ZW; Gao Y; Xu Y; Chen C; Zheng ZS; Weng HW; Ye S; Kuang M; Xie D; Peng S
Oncogene; 2018 May; 37(20):2660-2675. PubMed ID: 29483646
[TBL] [Abstract][Full Text] [Related]
38. 18β-glycyrrhetinic acid regulates mitochondrial ribosomal protein L35-associated apoptosis signaling pathways to inhibit proliferation of gastric carcinoma cells.
Yuan L; Yang Y; Li X; Zhou X; Du YH; Liu WJ; Zhang L; Yu L; Ma TT; Li JX; Chen Y; Nan Y
World J Gastroenterol; 2022 Jun; 28(22):2437-2456. PubMed ID: 35979263
[TBL] [Abstract][Full Text] [Related]
39. MiR-515-5p acts as a tumor suppressor via targeting TRIP13 in prostate cancer.
Zhang X; Zhou J; Xue D; Li Z; Liu Y; Dong L
Int J Biol Macromol; 2019 May; 129():227-232. PubMed ID: 30685303
[TBL] [Abstract][Full Text] [Related]
40. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer.
Sun M; Jin FY; Xia R; Kong R; Li JH; Xu TP; Liu YW; Zhang EB; Liu XH; De W
BMC Cancer; 2014 May; 14():319. PubMed ID: 24884417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
